Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application.
Nociceptive impulse activity was recorded extracellularly from single A delta and C primary afferents of the guinea pig's medial articular nerve after induction of an experimental osteoarthritis in the knee joint by partial medial menisectomy and transection of the anterior cruciate ligament (PMM+TACL). Also, the analgesic effects of intra-articular hyaluronan solutions were evaluated. Healthy, PMM+TACL operated, sham-operated (opening of the joint capsule without PMM and TACL surgery) and acutely inflamed (intra-articular kaolin-carrageenan, K-C) animals were used. The stimulus protocol consisted of torque meter-controlled, standardized innocuous and noxious inward and outward rotations of the joint. This stimulus protocol of 50 s duration was repeated every 5 min for 70 min. One day, one week and three weeks after PMM+TACL, the movement-evoked discharges of A delta articular afferents were increased significantly over values found in sham-operated animals. The discharges of C fibers were significantly augmented only one week after PMM+TACL surgery. Filling of the joint cavity with a high viscosity hyaluronan solution (hylan G-F 20, Synvisc) immediately and three days after surgery reduced significantly the enhanced nerve activity observed in joint afferent fibers one day and one week after surgery. Augmentation of movement-evoked discharges in K-C acutely inflamed knee joints was similar to that observed one week after PMM+TACL. Our results indicate that in the PMM+TACL model of osteoarthritis in guinea pigs, enhancement of nociceptive responses to joint movement was primarily associated to post-surgical inflammation. Intra-articular injection of an elastoviscous hyaluronan solution reduced the augmented nerve activity.
Gomis
Ana
A
Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, 03550 Sant Joan d'Alacant, Spain. agomis@umh.es
Miralles
Ana
A
Schmidt
Robert F
RF
Belmonte
Carlos
C
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D016118:Anterior Cruciate Ligament / Q000187:drug effects / Q000294:innervation / Q000601:surgery; D002351:Carrageenan; D004195:Disease Models, Animal; D019054:Evoked Potentials, Motor / Q000187:drug effects / Q000502:physiology; D005260:Female; D006168:Guinea Pigs; D006820:Hyaluronic Acid / Q000494:pharmacology*; D007270:Injections, Intra-Articular; D007593:Joint Instability / Q000188:drug therapy / Q000503:physiopathology; D007616:Kaolin; D007719:Knee Joint / Q000187:drug effects / Q000294:innervation / Q000601:surgery; D008297:Male; D008592:Menisci, Tibial / Q000187:drug effects / Q000294:innervation / Q000601:surgery; D009068:Movement / Q000502:physiology; D009431:Neural Conduction; D009619:Nociceptors / Q000187:drug effects* / Q000502:physiology; D020370:Osteoarthritis, Knee / Q000188:drug therapy* / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D012996:Solutions
D000276:Adjuvants, Immunologic; D012996:Solutions; D007616:Kaolin; D002351:Carrageenan; D006820:Hyaluronic Acid